Comparative Controlled Study of Analgesic, Antiasthenic and Anti-Anxiety Effects of Xenon in Patients With Parkinson's Disease
Clinical trial NCT04097080 · UNKNOWN
Trial details
- NCT number
- NCT04097080
- Sponsor
- Nobilis Therapeutics Inc.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-15
- Primary completion
- 2021-11-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.